nach oben

Journal of Endocrinological Investigation

11.05.2024 | Original Article

Sociodemographic profile, health-related behaviours and experiences of healthcare access in Italian transgender and gender diverse adult population

verfasst von: M. Marconi, M. T. Pagano, J. Ristori, S. Bonadonna, R. Pivonello, M. C. Meriggiola, G. Motta, F. Lombardo, M. Mosconi, A. Oppo, C. Cocchetti, A. Romani, S. Federici, L. Bruno, N. Verde, A. Lami, C. M. Crespi, L. Marinelli, L. Giordani, P. Matarrese, A. Ruocco, C. Santangelo, B. Contoli, M. Masocco, V. Minardi, F. Chiarotti, A. D. Fisher, M. Pierdominici

Erschienen in: Journal of Endocrinological Investigation

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Information on the general health of transgender and gender diverse (TGD) individuals continues to be lacking. To bridge this gap, the National Institute of Health in Italy together with the National Office against Racial Discriminations, clinical centres, and TGD organizations carried out a cross-sectional study to define the sociodemographic profile, health-related behaviours, and experiences of healthcare access in Italian TGD adult population.

Methods

A national survey was conducted by Computer-Assisted Web Interviewing (CAWI) technique. Collected data were compared within the TGD subgroups and between TGD people and the Italian general population (IGP).

Results

TGD respondents were 959: 65% assigned female at birth (AFAB) and 35% assigned male at birth (AMAB). 91.8% and 8.2% were binary and non-binary TGD respondents, respectively. More than 20% of the TGD population reported to be unemployed with the highest rate detectable in AMAB and non-binary people. Cigarette smoking and binge drinking were higher in the TGD population compared with IGP (p < 0.05), affecting TGD subgroups differently. A significant lower percentage of AFAB TGD people reported having had screening for cervical and breast cancer in comparison with AFAB IGP (p < 0.0001, in both cases). Over 40% was the percentage of AFAB and non-binary TGD people accessing healthcare who felt discriminated against because of their gender identity.

Conclusions

Our results are a first step towards a better understanding of the health needs of TGD people in Italy in order to plan the best policy choices for a more inclusive public health.

Nur mit Berechtigung zugänglich

Coleman E, Radix AE, Bouman WP et al (2022) Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 23(Suppl 1):S1–S259. https://doi.org/10.1080/26895269.2022.2100644CrossRefPubMedPubMedCentral

Zhang Q, Goodman M, Adams N et al (2020) Epidemiological considerations in transgender health: a systematic review with focus on higher quality data. Int J Transgend Health 21(2):125–137. https://doi.org/10.1080/26895269.2020.1753136CrossRefPubMedPubMedCentral

Fisher A, Marconi M, Castellini G et al (2024) Estimate and needs of the transgender adult population in Italy: the spot study. J Endocrinol Invest. https://doi.org/10.1007/s40618-023-02251-9CrossRefPubMed

Wiepjes CM, Nota NM, de Blok CJM et al (2018) The amsterdam cohort of gender dysphoria study (1972–2015): trends in prevalence, treatment, and regrets. J Sex Med 15(4):582–590. https://doi.org/10.1016/j.jsxm.2018.01.016CrossRefPubMed

Leinung MC, Joseph J (2020) Changing demographics in transgender individuals seeking hormonal therapy: are trans women more common than trans men? Transgend Health 5(4):241–245. https://doi.org/10.1089/trgh.2019.0070CrossRefPubMedPubMedCentral

Reisner SL, Poteat T, Keatley J et al (2016) Global health burden and needs of transgender populations: a review. Lancet 388(10042):412–436. https://doi.org/10.1016/S0140-6736(16)00684-XCrossRefPubMedPubMedCentral

Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, Wylie K (2016) Transgender people: health at the margins of society. Lancet 388(10042):390–400. https://doi.org/10.1016/S0140-6736(16)00683-8CrossRefPubMed

EU Agency for Fundamental Rights (2020) A long way to go for LGBTI equality: technical report. Luxembourg. https://fra.europa.eu/sites/default/files/fra_uploads/fra-2020-lgbti-equality-technical-report_en.pdf. Accessed 7 Dec 2022

Reisner SL, Deutsch MB, Bhasin S et al (2016) Advancing methods for US transgender health research. Curr Opin Endocrinol Diabetes Obes 23(2):198–207. https://doi.org/10.1097/MED.0000000000000229CrossRefPubMedPubMedCentral

10.

ISTAT, Istituto Nazionale di Statistica (2017) Forme, livelli e dinamiche dell’urbanizzazione in Italia. https://www.istat.it/it/files/2017/05/Urbanizzazione.pdf. Accessed 7 Dec 2022

11.

National health service: essential levels of assistance. Preventive healthcare measures. https://www.salute.gov.it/portale/lea/dettaglioContenutiLea.jsp?lingua=english&id=5442&area=Lea&menu=prevLea. Accessed 7 Dec 2022

12.

Distante V, Ciatto S, Frigerio A et al (2007) Recommendations of a national Italian consensus conference on the opportunity of extending screening service by mammography to 40–49 and 70–74 years of age women. Epidemiol Prev 31(1):15–22PubMed

13.

ISTAT, Istituto Nazionale di Statistica. Resident population on 1st January 2021. https://esploradati.istat.it/databrowser/#/it/dw/categories/IT1,POP,1.0/POP_POPULATION/DCIS_POPRES1/IT1,22_289_DF_DCIS_POPRES1_1,1.0. Accessed 7 Dec 2022

14.

Fisher AD, Bandini E, Casale H et al (2013) Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. J Sex Med 10(2):408–419. https://doi.org/10.1111/j.1743-6109.2012.03006.xCrossRefPubMed

15.

Baldissera S, Ferrante G, Quarchioni E et al (2014) Field substitution of nonresponders can maintain sample size and structure without altering survey estimates-the experience of the Italian behavioral risk factors surveillance system (PASSI). Ann Epidemiol 24(4):241–245. https://doi.org/10.1016/j.annepidem.2013.12.003CrossRefPubMed

16.

Baldissera S, Campostrini S, Binkin N et al (2011) Features and initial assessment of the Italian behavioral risk factor surveillance system (PASSI), 2007–2008. Prev Chronic Dis 8(1):A24PubMed

17.

Romani A, Mazzoli F, Ristori J et al (2021) Psychological wellbeing and perceived social acceptance in gender diverse individuals. J Sex Med 18(11):1933–1944. https://doi.org/10.1016/j.jsxm.2021.08.012CrossRefPubMed

18.

Leppel K (2021) Transgender men and women in 2015: employed, unemployed, or not in the labor force. J Homosex 68(2):203–229. https://doi.org/10.1080/00918369.2019.1648081CrossRefPubMed

19.

Aparicio-García ME, Díaz-Ramiro EM, Rubio-Valdehita S, López-Núñez MI, García-Nieto I (2018) Health and well-being of cisgender transgender and non-binary young people. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph15102133CrossRefPubMedPubMedCentral

20.

Azagba S, Latham K, Shan L (2019) Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States. Int J Drug Policy 73:163–169. https://doi.org/10.1016/j.drugpo.2019.07.024CrossRefPubMed

21.

Buchting FO, Emory KT, Scout KY, Fagan P, Vera LE, Emery S (2017) Transgender use of cigarettes, cigars, and E-cigarettes in a national study. Am J Prev Med 53(1):e1–e7. https://doi.org/10.1016/j.amepre.2016.11.022CrossRefPubMedPubMedCentral

22.

Tamí-Maury I, Sharma A, Chen M, Blalock J, Ortiz J, Weaver L, Shete S (2020) Comparing smoking behavior between female-to-male and male-to-female transgender adults. Tob Prev Cessat. https://doi.org/10.18332/tpc/114513CrossRefPubMedPubMedCentral

23.

Hughto JMW, Quinn EK, Dunbar MS, Rose AJ, Shireman TI, Jasuja GK (2021) Prevalence and co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and cisgender adults. JAMA Netw Open 4(2):e2036512. https://doi.org/10.1001/jamanetworkopen.2020.36512CrossRefPubMedPubMedCentral

24.

Kittaneh AA, Patel S, Sidhu NK, Lechner WV, Kenne DR (2021) Tobacco use status as a function of transgender identity: the mediating role of psychological distress. Tob Use Insights 14:1179173X211004267. https://doi.org/10.1177/1179173X211004267CrossRefPubMedPubMedCentral

25.

Downing JM, Przedworski JM (2018) Health of transgender adults in the U.S., 2014–2016. Am J Prev Med 55(3):336–344. https://doi.org/10.1016/j.amepre.2018.04.045CrossRefPubMed

26.

Sawyer AN, Bono RS, Kaplan B, Breland AB (2022) Nicotine/tobacco use disparities among transgender and gender diverse adults: findings from wave 4 PATH data. Drug Alcohol Depend 232:109268. https://doi.org/10.1016/j.drugalcdep.2022.109268CrossRefPubMedPubMedCentral

27.

Mahalik JR, Burns SM, Syzdek M (2007) Masculinity and perceived normative health behaviors as predictors of men’s health behaviors. Soc Sci Med 64(11):2201–2209. https://doi.org/10.1016/j.socscimed.2007.02.035CrossRefPubMed

28.

Wheldon CW, Watson RJ, Fish JN, Gamarel K (2019) Cigarette smoking among youth at the intersection of sexual orientation and gender identity. LGBT Health 6(5):235–241. https://doi.org/10.1089/lgbt.2019.0005CrossRefPubMedPubMedCentral

29.

Coulter RW, Blosnich JR, Bukowski LA, Herrick AL, Siconolfi DE, Stall RD (2015) Differences in alcohol use and alcohol-related problems between transgender- and nontransgender-identified young adults. Drug Alcohol Depend 154:251–259. https://doi.org/10.1016/j.drugalcdep.2015.07.006CrossRefPubMedPubMedCentral

30.

Day JK, Fish JN, Perez-Brumer A, Hatzenbuehler ML, Russell ST (2017) Transgender youth substance use disparities: results from a population-based sample. J Adolesc Health 61(6):729–735. https://doi.org/10.1016/j.jadohealth.2017.06.024CrossRefPubMedPubMedCentral

31.

Reisner SL, Greytak EA, Parsons JT, Ybarra ML (2015) Gender minority social stress in adolescence: disparities in adolescent bullying and substance use by gender identity. J Sex Res 52(3):243–256. https://doi.org/10.1080/00224499.2014.886321CrossRefPubMed

32.

Gamarel KE, Mereish EH, Manning D, Iwamoto M, Operario D, Nemoto T (2016) Minority stress, smoking patterns, and cessation attempts: findings from a community-sample of transgender women in the san francisco bay area. Nicotine Tob Res 18(3):306–313. https://doi.org/10.1093/ntr/ntv066CrossRefPubMed

33.

Shires DA, Jaffee KD (2016) Structural discrimination is associated with smoking status among a national sample of transgender individuals. Nicotine Tob Res 18(6):1502–1508. https://doi.org/10.1093/ntr/ntv221CrossRefPubMed

34.

Hatzenbuehler ML, Phelan JC, Link BG (2013) Stigma as a fundamental cause of population health inequalities. Am J Public Health 103(5):813–821. https://doi.org/10.2105/AJPH.2012.301069CrossRefPubMedPubMedCentral

35.

de Blok CJM, Dreijerink KMA, den Heijer M (2019) Cancer risk in transgender people. Endocrinol Metab Clin North Am 48(2):441–452. https://doi.org/10.1016/j.ecl.2019.02.005CrossRefPubMed

36.

Braun H, Nash R, Tangpricha V, Brockman J, Ward K, Goodman M (2017) Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev 39(1):93–107. https://doi.org/10.1093/epirev/mxw003CrossRefPubMedPubMedCentral

37.

Leone AG, Casolino R, Trapani D et al (2023) Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the assisi recommendations. EClinicalMedicine 65:102277. https://doi.org/10.1016/j.eclinm.2023.102277CrossRefPubMedPubMedCentral

38.

Bazzi AR, Whorms DS, King DS, Potter J (2015) Adherence to mammography screening guidelines among transgender persons and sexual minority women. Am J Public Health 105(11):2356–2358. https://doi.org/10.2105/AJPH.2015.302851CrossRefPubMedPubMedCentral

39.

Luehmann N, Ascha M, Chwa E et al (2022) A single-center study of adherence to breast cancer screening mammography guidelines by transgender and non-binary patients. Ann Surg Oncol 29(3):1707–1717. https://doi.org/10.1245/s10434-021-10932-zCrossRefPubMed

40.

Tabaac AR, Sutter ME, Wall CSJ, Baker KE (2018) Gender identity disparities in cancer screening behaviors. Am J Prev Med 54(3):385–393. https://doi.org/10.1016/j.amepre.2017.11.009CrossRefPubMed

41.

Kiran T, Davie S, Singh D, Hranilovic S, Pinto AD, Abramovich A, Lofters A (2019) Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data. Can Fam Physician 65(1):e30–e37PubMedPubMedCentral

42.

Scheim A, Bauer G (2013) Breast and cervical cancer screening among trans Ontarians: a report prepared for the Screening Saves Lives Program of the Canadian Cancer Society. Trans PULSE Project. https://www.transpulseproject.ca. Accessed 7 Dec 2022

43.

Heer E, Peters C, Knight R, Yang L, Heitman SJ (2023) Participation, barriers, and facilitators of cancer screening among LGBTQ+ populations: a review of the literature. Prev Med 170:107478. https://doi.org/10.1016/j.ypmed.2023.107478CrossRefPubMed

44.

Peitzmeier SM, Agénor M, Bernstein IM et al (2017) “It can promote an existential crisis”: Factors influencing pap test acceptability and utilization among transmasculine individuals. Qual Health Res 27(14):2138–2149. https://doi.org/10.1177/1049732317725513CrossRefPubMed

45.

Peitzmeier SM, Khullar K, Reisner SL, Potter J (2014) Pap test use is lower among female-to-male patients than non-transgender women. Am J Prev Med 47(6):808–812. https://doi.org/10.1016/j.amepre.2014.07.031CrossRefPubMed

46.

James SEHJ, Rankin S, Keisling M, Mottet LAA (2016) The report of the 2015 US Transgender Survey. https://www.ustranssurvey.org/reports. Accessed 7 Dec 2022

47.

Agénor M, White Hughto JM, Peitzmeier SM, Potter J, Deutsch MB, Pardee DJ, Reisner SL (2018) Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults. J Gen Intern Med 33(7):1015–1017. https://doi.org/10.1007/s11606-018-4400-3CrossRefPubMedPubMedCentral

48.

Carroll R, Tan KKH, Ker A, Byrne JL, Veale JF (2023) Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand. Aust N Z J Obstet Gynaecol 63(3):448–453. https://doi.org/10.1111/ajo.13674CrossRefPubMed

49.

Agénor M, Peitzmeier SM, Bernstein IM et al (2016) Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives. Cult Health Sex 18(10):1192–1206. https://doi.org/10.1080/13691058.2016.1177203CrossRefPubMed

50.

Nicholls EJ, McGowan CR, Miles S et al (2023) Provision of cervical screening for transmasculine patients: a review of clinical and programmatic guidelines. BMJ Sex Reprod Health 49(2):118–128. https://doi.org/10.1136/bmjsrh-2022-201526CrossRefPubMed

51.

Roznovjak D, Petroll AE, Lakatos AEB, Narayan R, Cortina CS (2023) Perceptions of transgender and nonbinary persons toward breast and cervical cancer development, screening, and potential impact on gender-affirming hormone therapy. JCO Oncol Pract OP2200681. https://doi.org/10.1200/OP.22.00681CrossRef

52.

Scheim AI, Perez-Brumer AG, Bauer GR (2020) Gender-concordant identity documents and mental health among transgender adults in the USA: a cross-sectional study. Lancet Public Health 5(4):e196–e203. https://doi.org/10.1016/S2468-2667(20)30032-3CrossRefPubMedPubMedCentral

53.

Kattari SK, Call J, Holloway BT, Kattari L, Seelman KL (2021) Exploring the experiences of transgender and gender diverse adults in accessing a trans knowledgeable primary care physician. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph182413057CrossRefPubMedPubMedCentral

54.

Drabish K, Theeke LA (2022) Health impact of stigma, discrimination, prejudice, and bias experienced by transgender people: a systematic review of quantitative studies. Issues Ment Health Nurs 43(2):111–118. https://doi.org/10.1080/01612840.2021.1961330CrossRefPubMed

55.

Jaffee KD, Shires DA, Stroumsa D (2016) Discrimination and delayed health care among transgender women and men: implications for improving medical education and health care delivery. Med Care 54(11):1010–1016. https://doi.org/10.1097/MLR.0000000000000583CrossRefPubMed

56.

de Vries E, Kathard H, Müller A (2020) Debate: Why should gender-affirming health care be included in health science curricula? BMC Med Educ 20(1):51. https://doi.org/10.1186/s12909-020-1963-6CrossRefPubMedPubMedCentral

57.

Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, Sevelius J (2016) Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes 23(2):168–171. https://doi.org/10.1097/MED.0000000000000227CrossRefPubMedPubMedCentral

58.

Feldman JL, Luhur WE, Herman JL, Poteat T, Meyer IH (2021) Health and health care access in the US transgender population health (TransPop) survey. Andrology 9(6):1707–1718. https://doi.org/10.1111/andr.13052CrossRefPubMedPubMedCentral

59.

National Academies of Sciences, Engineering, and Medicine (2020) Understanding the Well-Being of LGBTQI+ Populations. The National Academies Press, Washington, DC. https://doi.org/10.17226/25877

Titel: Sociodemographic profile, health-related behaviours and experiences of healthcare access in Italian transgender and gender diverse adult population
verfasst von: M. Marconi
M. T. Pagano
J. Ristori
S. Bonadonna
R. Pivonello
M. C. Meriggiola
G. Motta
F. Lombardo
M. Mosconi
A. Oppo
C. Cocchetti
A. Romani
S. Federici
L. Bruno
N. Verde
A. Lami
C. M. Crespi
L. Marinelli
L. Giordani
P. Matarrese
A. Ruocco
C. Santangelo
B. Contoli
M. Masocco
V. Minardi
F. Chiarotti
A. D. Fisher
M. Pierdominici
Publikationsdatum: 11.05.2024
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-024-02362-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Sociodemographic profile, health-related behaviours and experiences of healthcare access in Italian transgender and gender diverse adult population

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin